These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18433468)

  • 21. Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease.
    Rigoli L; Romano C; Caruso RA; Lo Presti MA; Di Bella C; Procopio V; Lo Giudice G; Amorini M; Costantino G; Sergi MD; Cuppari C; Calabro GE; Gallizzi R; Salpietro CD; Fries W
    World J Gastroenterol; 2008 Jul; 14(28):4454-61. PubMed ID: 18680223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants.
    Glas J; Seiderer J; Wetzke M; Konrad A; Török HP; Schmechel S; Tonenchi L; Grassl C; Dambacher J; Pfennig S; Maier K; Griga T; Klein W; Epplen JT; Schiemann U; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Folwaczny M; Mussack T; Brand S
    PLoS One; 2007 Sep; 2(9):e819. PubMed ID: 17786191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in the molecular dissection of inflammatory bowel disease.
    Siminovitch KA
    Semin Immunol; 2006 Aug; 18(4):244-53. PubMed ID: 16679026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.
    Weersma RK; Zhou L; Nolte IM; van der Steege G; van Dullemen HM; Oosterom E; Bok L; Peppelenbosch MP; Faber KN; Kleibeuker JH; Dijkstra G
    Inflamm Bowel Dis; 2008 Dec; 14(12):1615-22. PubMed ID: 18668679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics of tumors derived from colorectal cancer patients who harbor the tumor necrosis factor alpha-1031T/T and NOD2 3020insC polymorphism.
    Kładny J; Suchy J; Kłujszo-Grabowska E; Kacperski T; Scott RJ; Kurzawski G; Lubiński J
    Cancer Epidemiol; 2009 Aug; 33(2):161-3. PubMed ID: 19679065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extreme heterogeneity in CARD15 and DLG5 Crohn disease-associated polymorphisms between German and Norwegian populations.
    Medici V; Mascheretti S; Croucher PJ; Stoll M; Hampe J; Grebe J; Sturniolo GC; Solberg C; Jahnsen J; Moum B; Schreiber S; Vatn MH
    Eur J Hum Genet; 2006 Apr; 14(4):459-68. PubMed ID: 16493449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of Genetic Polymorphisms of Inflammation Response Genes on Sporadic Colorectal Cancer Predisposition Risk in Malaysian Patients - A Case Control Study.
    Ankathil R; Mustapha MA; Abdul Aziz AA; Mohd Shahpudin SN; Zakaria AD; Abu Hassan MR; Musa KI
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1621-1632. PubMed ID: 31244280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ulcerative colitis neoplasia is not associated with common inflammatory bowel disease single-nucleotide polymorphisms.
    Connelly TM; Berg AS; Harris LR; Brinton DL; Hegarty JP; Deiling SM; Stewart DB; Koltun WA
    Surgery; 2014 Aug; 156(2):253-62. PubMed ID: 24947639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors and gene polymorphisms of inflammatory bowel disease in population of Zhejiang, China.
    Wang ZW; Ji F; Teng WJ; Yuan XG; Ye XM
    World J Gastroenterol; 2011 Jan; 17(1):118-22. PubMed ID: 21218092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in the genetics of inflammatory bowel disease.
    Cho JH
    Curr Gastroenterol Rep; 2004 Dec; 6(6):467-73. PubMed ID: 15527676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The lL-8 and IL-13 gene polymorphisms in inflammatory bowel disease and colorectal cancer.
    Walczak A; Przybylowska K; Dziki L; Sygut A; Chojnacki C; Chojnacki J; Dziki A; Majsterek I
    DNA Cell Biol; 2012 Aug; 31(8):1431-8. PubMed ID: 22741617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should family members of IBD patients be screened for CARD15/NOD2 mutations?
    Vermeire S; Van Assche G; Rutgeerts P
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S190-1. PubMed ID: 18816704
    [No Abstract]   [Full Text] [Related]  

  • 33. Genotype and phenotype relation in inflammatory bowel disease.
    Kinouchi Y; Negoro K; Takagi S; Takahashi S; Shimosegawa T
    J Gastroenterol; 2005 Mar; 40 Suppl 16():21-4. PubMed ID: 15902959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CTLA-4 (+49A/G) and NOD2/CARD15 (N852S) polymorphisms with inflammatory bowel disease in Turkish patients.
    Budak Diler S; Yaraş S
    Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):97-101. PubMed ID: 30213296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations between single-nucleotide polymorphisms and inflammatory bowel disease-associated colorectal cancers in inflammatory bowel disease patients: a meta-analysis.
    Li H; Jin Z; Li X; Wu L; Jin J
    Clin Transl Oncol; 2017 Aug; 19(8):1018-1027. PubMed ID: 28243990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of the OCTN1/1672T variant with increased risk for colorectal cancer in young individuals and ulcerative colitis patients.
    Martini M; Ferrara AM; Giachelia M; Panieri E; Siminovitch K; Galeotti T; Larocca LM; Pani G
    Inflamm Bowel Dis; 2012 Mar; 18(3):439-48. PubMed ID: 21793125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of NOD1/CARD4 and NOD2/CARD15 gene polymorphisms in cancer etiology.
    Kutikhin AG
    Hum Immunol; 2011 Oct; 72(10):955-68. PubMed ID: 21745515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphisms in Turkish patients with inflammatory bowel disease.
    Ozen SC; Dagli U; Kiliç MY; Törüner M; Celik Y; Ozkan M; Soykan I; Cetinkaya H; Ulker A; Ozden A; Bozdayi AM
    J Gastroenterol; 2006 Apr; 41(4):304-10. PubMed ID: 16741608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic variation in DLG5 is associated with inflammatory bowel disease.
    Stoll M; Corneliussen B; Costello CM; Waetzig GH; Mellgard B; Koch WA; Rosenstiel P; Albrecht M; Croucher PJ; Seegert D; Nikolaus S; Hampe J; Lengauer T; Pierrou S; Foelsch UR; Mathew CG; Lagerstrom-Fermer M; Schreiber S
    Nat Genet; 2004 May; 36(5):476-80. PubMed ID: 15107852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory bowel disease in Ashkenazi Jews: implications for familial colorectal cancer.
    Lynch HT; Brand RE; Locker GY
    Fam Cancer; 2004; 3(3-4):229-32. PubMed ID: 15516846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.